All In Biotech

Drug Trial Radar · NCT03996447

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Last checked: Nov 20, 2026Latest source record: Sep 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

260

Actual

Start

Jun 3, 2019

Primary completion

Sep 11, 2020

Study completion Sep 11, 2020

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
First posted
Jun 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial aimed to evaluate the Efficacy and Safety of gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Conditions

  • CNS Lesion
  • Blood Brain Barrier Defect

Interventions

  • gadopiclenolDrug

    single intravenous (IV) bolus injection at a rate of 2ml/second

  • Gadobutrol 1Mmol/mL Solution for Injection VialDrug

    single intravenous (IV) bolus injection at a rate of 2ml/second

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lesion Visualization Comparing Gadopiclenol-enhanced MRI to Unenhanced MRITime frame: At first MRI examination (gadopiclenol-enhanced MRI) for patients of Arm 1. At second MRI examination (gadopiclenol-enhanced MRI) for patients of Arm 2, performed 2-14 days after gadobutrol-enhanced MRI.

Locations

33 sites in 11 countries. Site status is shown where the registry gives one.

  • ASCLEPES Research Centers

    Panorama City, California

  • University of Connecticut Health Center

    Farmington, Connecticut

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Northwest Neurology, Ltd.

    Rolling Meadows, Illinois

  • University of Missouri Hospital and Clinic

    Columbia, Missouri

  • University Of Pennsylvania

    Philadelphia, Pennsylvania

  • South Carolina Clinical & Translational Research (SCTR) Institute

    Charleston, South Carolina

  • University Of Washington - Medical Center

    Seattle, Washington

  • ZNA Middelheim

    Antwerp, Belgium

  • UZ Brussel - Campus Jette

    Brussels, Belgium

  • CHRU - Hôpital Roger Salengro - Neurologie

    Lille, France

  • Centre Hospitalier Sainte-Anne

    Paris, France

  • CHU La Miletrie

    Poitiers, France

  • CHRU Strasbourg Hôpital de Hautepierre

    Strasbourg, France

  • Uniklinik Mannheim

    Mannheim, Germany

  • Semmelweis Egyetem - Neurology

    Budapest, Hungary

  • Orszagos Klinikai Idegtudomanyi Intezet

    Budapest, Hungary

  • Debreceni Egyetem Klinikai Kozpont

    Debrecen, Hungary

  • Pecsi Tudomanyegyetem Klinikai Kozpont - Idegsebeszeti Klinika

    Pécs, Hungary

  • Szegedi Tudomanyegyetem AOK

    Szeged, Hungary

  • ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila, Ospedale Regionale San Salvatore

    L’Aquila, Italy

  • Fondazione I.R.C.C.S. C.Mondino

    Pavia, Italy

  • Istituto Neurologico Mediterraneo-Neuromed, I.R.C.C.S.

    Pozzilli, Italy

  • Azienda Sanitaria Universitaria Integrata di Trieste-PO Cattinara

    Trieste, Italy

  • Axis Heilsa S. de R.L. de C.V. (Althian)

    Monterrey, Mexico

  • Clinical Research Institute S.C

    Tlalnepantla, Mexico

  • Uniwersyteckie Centrum Kliniczne w Gdańsku, Zakład Radiologii

    Gdansk, Poland

  • Konkuk University Medical Center

    Seoul, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Hospital del Mar

    Barcelona, Spain

  • M.D. Anderson Cancer Center Madrid

    Madrid, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Taipei Veterans General Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.